Mandatory Procurement from MSEs Under MSMED Act: Supreme Court's Directive

Introduction

In a significant ruling, the Supreme Court of India addressed the rights of Micro and Small Enterprises (MSEs) concerning government procurement. The judgment clarifies the enforceability of the Public Procurement Policy for MSEs under the Micro, Small and Medium Enterprises Development Act, 2006 (MSMED Act) and scrutinizes the legality of minimum turnover clauses in government tenders. This decision is pivotal for MSEs seeking to participate in public procurement processes, ensuring that their rights are recognized and protected.

Case Background

The petitioners, LifeCare Innovations Pvt. Ltd. and its founder Dr. Jitendra Nath Verma, are engaged in the pharmaceuticals and medical biotechnology sector. They manufacture a critical life-saving drug, Liposomal Amphotericin B Suspension in Saline-Fungisome (LAmB), which has been recognized by the Government of India as essential for treating serious fungal infections. Despite their contributions, the petitioners faced disqualification from public procurement processes due to mandatory minimum turnover clauses in tender notifications issued by government entities.

The petitioners contended that these clauses were arbitrary and discriminatory, violating their rights under Articles 14 and 19 of the Constitution. They sought directions for the government to consider bids from MSEs without imposing minimum turnover requirements and to quash the existing tender notifications that included such clauses.

What The Lower Authorities Held

The High Court of Punjab and Haryana had previously dismissed the petitioners' writ petition challenging the tender issued by the Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh. The dismissal was based on the argument that the minimum turnover requirements were contractual in nature and thus not subject to judicial review. The petitioners subsequently approached the Supreme Court under Article 32 of the Constitution, seeking broader directions regarding the procurement policies affecting MSEs.

The Court's Reasoning

The Supreme Court, led by Justice Pamidighantam Sri Narasimha, examined two primary questions: whether the MSMED Act mandates procurement of 25% of goods and services from MSEs, and whether minimum turnover clauses in tenders violate constitutional provisions and the Procurement Order 2012.

The Court affirmed that while the MSMED Act does not create an individual enforceable right for MSEs, it establishes a statutory framework that imposes enforceable duties on government authorities to procure a minimum of 25% of their supplies from MSEs. The Procurement Order 2012, formulated under Section 11 of the MSMED Act, was recognized as having the force of law, thereby mandating compliance by government entities.

The Court emphasized that the minimum turnover clauses in tenders could potentially undermine the objectives of the Procurement Order 2012. It highlighted that such clauses must not be arbitrary and should have a rational nexus with the procurement objectives. The Court noted that the imposition of these clauses often disproportionately affects MSEs, which typically have lower turnover figures compared to larger competitors.

The Court also underscored the importance of judicial review in ensuring that the statutory bodies established under the MSMED Act function effectively and efficiently. It directed that the Review Committee and Grievance Cell, established under the Procurement Order 2012, must examine the limits of minimum turnover clauses and issue appropriate guidelines to ensure compliance with the procurement policy.

Statutory Interpretation

The judgment involved a detailed interpretation of the MSMED Act and the Procurement Order 2012. The Court reiterated that Section 11 of the MSMED Act empowers the Central and State Governments to formulate procurement preference policies for MSEs. The Procurement Order 2012 mandates that every government ministry and department must set annual procurement goals from MSEs, ultimately achieving a minimum of 25% of total annual purchases.

The Court's interpretation emphasized that while the government has the discretion to set eligibility criteria for tenders, such criteria must align with the overarching goal of promoting MSEs. The judgment clarified that minimum turnover clauses should not be used to circumvent the statutory obligations imposed by the Procurement Order 2012.

Why This Judgment Matters

This ruling is significant for several reasons. Firstly, it reinforces the statutory rights of MSEs in public procurement, ensuring that they are not unjustly excluded from government contracts due to arbitrary financial thresholds. Secondly, it establishes a framework for judicial review of government procurement practices, promoting transparency and accountability in the procurement process.

Moreover, the judgment highlights the need for effective grievance redressal mechanisms for MSEs, ensuring that their concerns regarding unreasonable tender conditions are addressed. This ruling is expected to empower MSEs, fostering a more inclusive and equitable procurement environment in India.

Final Outcome

The Supreme Court disposed of the writ petition with specific directions for the Review Committee and Grievance Cell to examine the issues surrounding mandatory procurement from MSEs and the limits of minimum turnover clauses. The Court mandated that these bodies take necessary actions within 60 days to ensure compliance with the Procurement Order 2012 and to issue appropriate policy guidelines.

Case Details

• Case Title: LIFECARE INNOVATIONS PVT. LTD. & ANR. VERSUS UNION OF INDIA & ORS.
• Citation: 2025 INSC 269
• Court: IN THE SUPREME COURT OF INDIA
• Bench: Justice Pamidighantam Sri Narasimha
• Date of Judgment: 2025-02-25